Prostate cancer screening with MRI does not differ from PSA only for detection but reduces biopsies and overdiagnosis

被引:0
|
作者
Wilt, Timothy J. [1 ,2 ]
Dahm, Philipp [1 ,2 ]
机构
[1] Minneapolis VA Hlth Care Syst, Minneapolis, MN 55417 USA
[2] Univ Minnesota, Minneapolis, MN 55455 USA
关键词
D O I
10.7326/ANNALS-24-01275-JC
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Source Citation Fazekas T, Shim SR, Basile G, et al. Magnetic resonance imaging in prostate cancer screening: a systematic review and meta-analysis. JAMA Oncol. 2024;10:745-754. 38576242 Clinical Impact Ratings GIM/FP/GP: Public Health:
引用
收藏
页码:JC94 / JC94
页数:1
相关论文
共 50 条
  • [31] PSA screening said to reduce prostate-cancer deaths, or does it?
    McCarthy, M
    LANCET, 1998, 351 (9115): : 1563 - 1563
  • [32] Review: Prostate cancer screening using PSA does not decrease mortality
    Luckmann, Roger
    ANNALS OF INTERNAL MEDICINE, 2011, 154 (02)
  • [34] Low PSA levels cannot rule out prostate cancer: Prostate cancer detection rates with respect to PSA levels results from a PSA based screening cohort
    Horninger, Wolfgang
    Klocker, Helmut
    Bektic, Jasmin
    Pelzer, Alexandre E.
    Schaefer, Georg
    Brunner, Andrea
    Achleitner, Regina
    Bartsch, Georg
    JOURNAL OF UROLOGY, 2007, 177 (04): : 203 - 204
  • [35] Prostate cancer detection rate at low PSA levels: Results from the Tyrol PSA-screening project
    Horninger, W
    Volgger, H
    Niescher, M
    Rogatsch, H
    Klocker, H
    Bartsch, G
    JOURNAL OF UROLOGY, 2002, 167 (04): : 324 - 325
  • [36] Anterior lobe prostate biopsies - detection of prostate cancer in men with increasing PSA and negative trans-rectal ultrasound prostate biopsies
    Bekarma, H. J.
    Mohammed, M.
    Nairn, R.
    Hollins, G.
    Clark, R.
    Meddings, R. N.
    Gurun, M.
    SCOTTISH MEDICAL JOURNAL, 2013, 58 (03) : E31 - E31
  • [37] Repeated TRUS biopsies: does it improve prostate cancer detection?
    Maarof, S. N. M.
    Kuppusamy, S.
    Ong, T. A.
    Razack, A. H.
    BJU INTERNATIONAL, 2015, 116 : 5 - 5
  • [38] Mean sojourn time, overdiagnosis, and reduction in advanced stage prostate cancer due to screening with PSA: implications of sojourn time on screening
    Pashayan, N.
    Duffy, S. W.
    Pharoah, P.
    Greenberg, D.
    Donovan, J.
    Martin, R. M.
    Hamdy, F.
    Neal, D. E.
    BRITISH JOURNAL OF CANCER, 2009, 100 (07) : 1198 - 1204
  • [39] Mean sojourn time, overdiagnosis, and reduction in advanced stage prostate cancer due to screening with PSA: implications of sojourn time on screening
    N Pashayan
    S W Duffy
    P Pharoah
    D Greenberg
    J Donovan
    R M Martin
    F Hamdy
    D E Neal
    British Journal of Cancer, 2009, 100 : 1198 - 1204